Clinical Trials Browser

Phase 3 × Neoplasm Metastasis × Trastuzumab × Clear all

NCT02492711 2025-03-17

SOPHIA

Phase 3 Completed

624 enrolled 17 charts 2 FDA

Neoplasm Metastasis

NCT03811418 2019-11-26

ATTILA

Phase 3 Withdrawn

Neoplasm Metastasis

NCT00876395 2018-12-19

BOLERO-1

Phase 3 Completed

719 enrolled 25 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00637325 2008-03-17

TOP

Phase 3 Unknown

Neoplasm Metastasis